JATT
NYSEJATT II Acquisition Corp
IPO2026
Price$10.50+0.00 (+0.00%)
2026-04-172026-06-09
News · 26 weeks7-80%
2025-12-142026-06-07
Mix790d
- Other3(43%)
- Offering2(29%)
- SEC Filings2(29%)
Latest news
25 items- SECSEC Form 10-Q filed by JATT II Acquisition Corp10-Q - JATT II Acquisition Corp. (0002112446) (Filer)
- SECSEC Form SCHEDULE 13G filed by JATT II Acquisition CorpSCHEDULE 13G - JATT II Acquisition Corp. (0002112446) (Subject)
- SECJATT II Acquisition Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - JATT II Acquisition Corp. (0002112446) (Filer)
- SECSEC Form SCHEDULE 13G filed by JATT II Acquisition CorpSCHEDULE 13G - JATT II Acquisition Corp. (0002112446) (Subject)
- SECSEC Form SCHEDULE 13G filed by JATT II Acquisition CorpSCHEDULE 13G - JATT II Acquisition Corp. (0002112446) (Subject)
- PRJATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public OfferingWESTFIELD, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the "Company") announced the closing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share on April 20, 2026. Total gross proceeds from the offering were $60,000,000 before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The ordinary shares began trading on the Nasdaq Global Market ("NASDAQ") under the ticker symbol "JATT" on April 17, 2026. Guggenheim Securities, LLC is acting as sole book-running manager. The Company has granted the underwriters a 45-day option to purchase up to 900,000 additional ordi
- PRJATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public OfferingWESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share. The ordinary shares are expected to trade on the Nasdaq Global Market ("NASDAQ") under the ticker symbol "JATT" beginning April 17, 2026. The offering is expected to close on April 20, 2026, subject to customary closing conditions. Guggenheim Securities, LLC is acting as sole book-running manager. The Company has granted the underwriters a 45-day option to purcha
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- SECJATT Acquisition Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Zura Bio Ltd (0001855644) (Filer)
- INSIDERSEC Form 4 filed by Lisicki Robert4 - Zura Bio Ltd (0001855644) (Issuer)
- INSIDERSEC Form 4 filed by Ploos Van Amstel Arnout4 - Zura Bio Ltd (0001855644) (Issuer)
- INSIDERSEC Form 4 filed by Thiara Parvinder4 - Zura Bio Ltd (0001855644) (Issuer)
- INSIDERSEC Form 4 filed by Nistala Kiran4 - Zura Bio Ltd (0001855644) (Issuer)
- 13D/GSEC Form SC 13G/A filed by JATT Acquisition Corp (Amendment)SC 13G/A - Zura Bio Ltd (0001855644) (Subject)
- SECJATT Acquisition Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Zura Bio Ltd (0001855644) (Filer)
- INSIDERSEC Form 3 filed by new insider Lisicki Robert3 - Zura Bio Ltd (0001855644) (Issuer)
- SECJATT Acquisition Corp filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Zura Bio Ltd (0001855644) (Filer)
- SECJATT Acquisition Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Zura Bio Ltd (0001855644) (Filer)
- 13D/GSEC Form SC 13G filed by JATT Acquisition CorpSC 13G - Zura Bio Ltd (0001855644) (Subject)
- INSIDERThiara Parvinder sold $8,000,000 worth of Class A Ordinary Shares (2,000,000 units at $4.00) (SEC Form 4)4 - Zura Bio Ltd (0001855644) (Issuer)
JATT FAQ
4 questionsWhat does JATT II Acquisition Corp do?
JATT Acquisition Corp intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses primarily operating in the life sciences sector. The company was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.Where does JATT stock trade?
JATT II Acquisition Corp (JATT) is listed on NYSE.When did JATT II Acquisition Corp go public?
JATT II Acquisition Corp (JATT) completed its IPO in 2026.How can I track JATT on Quantisnow?
Quantisnow aggregates JATT II Acquisition Corp's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow JATT to receive live email and push alerts on every new disclosure.